Your browser doesn't support javascript.
loading
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome.
Crosbie, Emma J; Ryan, Neil A J; Arends, Mark J; Bosse, Tjalling; Burn, John; Cornes, Joanna M; Crawford, Robin; Eccles, Diana; Frayling, Ian M; Ghaem-Maghami, Sadaf; Hampel, Heather; Kauff, Noah D; Kitchener, Henry C; Kitson, Sarah J; Manchanda, Ranjit; McMahon, Raymond F T; Monahan, Kevin J; Menon, Usha; Møller, Pål; Möslein, Gabriela; Rosenthal, Adam; Sasieni, Peter; Seif, Mourad W; Singh, Naveena; Skarrott, Pauline; Snowsill, Tristan M; Steele, Robert; Tischkowitz, Marc; Evans, D Gareth.
Afiliação
  • Crosbie EJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK. Emma.crosbie@manchester.ac.uk.
  • Ryan NAJ; Directorate of Gynaecology, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. Emma.crosbie@manchester.ac.uk.
  • Arends MJ; Prevention Early Detection Theme, NIHR Biomedical Research Centre, The Christie NHS Foundation Trust, Manchester, UK. Emma.crosbie@manchester.ac.uk.
  • Bosse T; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.
  • Burn J; Division of Evolution and Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester, UK.
  • Cornes JM; Division of Pathology & Centre for Comparative Pathology, Cancer Research UK Edinburgh Centre, Institute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, UK.
  • Crawford R; Pathology Department, Leiden University Medical Center, Leiden, the Netherlands.
  • Eccles D; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
  • Frayling IM; Patient Representative, Cambridge, UK.
  • Ghaem-Maghami S; Department of Gynaecological Oncology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Hampel H; Faculty of Medicine, University of Southampton, University Hospital Southampton, Southampton, UK.
  • Kauff ND; Institute of Cancer and Genetics, Cardiff University, Cardiff, UK.
  • Kitchener HC; Department of Surgery and Cancer, Imperial College, London, UK.
  • Kitson SJ; Division of Human Genetics, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Manchanda R; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.
  • McMahon RFT; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.
  • Monahan KJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.
  • Menon U; Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Møller P; Department of Histopathology, Manchester University NHS Foundation Trust, Manchester, UK.
  • Möslein G; Chelsea & Westminster Hospital NHS Trust, London, UK.
  • Rosenthal A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
  • Sasieni P; Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, part of Oslo University Hospital, Oslo, Norway.
  • Seif MW; Research Group Inherited Cancer, Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
  • Singh N; Center for Hereditary Tumors, Helios University Hospital Wuppertal, University of Witten-, Herdecke, Germany.
  • Skarrott P; Center for Hereditary Tumors, Helios University Hospital Wuppertal, University of Witten-, Herdecke, Germany.
  • Snowsill TM; Department of Women's Cancer, UCL EGA Institute for Women's Health, University College London, London, UK.
  • Steele R; School of Cancer and Pharmaceutical Sciences, Kings College London, London, UK.
  • Tischkowitz M; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK.
  • Evans DG; Department of Cellular Pathology, Barts Health NHS Trust, London, UK.
Genet Med ; 21(10): 2390-2400, 2019 10.
Article em En | MEDLINE | ID: mdl-30918358
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Hereditárias sem Polipose / Neoplasias do Endométrio / Neoplasias dos Genitais Femininos Tipo de estudo: Diagnostic_studies / Guideline / Screening_studies Limite: Female / Humans País/Região como assunto: America do norte / Europa Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Hereditárias sem Polipose / Neoplasias do Endométrio / Neoplasias dos Genitais Femininos Tipo de estudo: Diagnostic_studies / Guideline / Screening_studies Limite: Female / Humans País/Região como assunto: America do norte / Europa Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido